Science Speaks Follows Ebola Research, Developments
The IDSA/HIVMA Science Speaks blog continued coverage of the current Ebola outbreak in the Democratic Republic of Congo and findings from the 2013-2016 West Africa crisis, with:
- a report on a retrospective study showing that the administration of intravenous fluids, in itself, did not improve Ebola patients’ 28-day survival rates;
- news of changes to the vaccination strategy in the Democratic Republic of Congo;
- and a roundup of articles discussing the challenges to efforts to contain the ongoing outbreak, including this opinion piece by IDSA Global Health Committee member Krutika Kuppalli, MD.